Sebban Hélène, Yamaoka Shoji, Courtois Gilles
INSERM U697, Hôpital Saint-Louis, Paris 75010, France.
Trends Cell Biol. 2006 Nov;16(11):569-77. doi: 10.1016/j.tcb.2006.09.004. Epub 2006 Sep 20.
NEMO, the regulatory subunit of the IkappaB kinase (IKK) complex that controls the activation of the transcription factor NF-kappaB, is required for IKK function in most situations, but its exact mode of action has remained elusive until recently. A series of publications now provides information about how posttranscriptional modifications of NEMO, such as ubiquitination, sumoylation or phosphorylation, regulate its function in the IKK complex. These modifications might also regulate a cytosolic pool of free NEMO that controls the activation of NF-kappaB induced by genotoxic stress. Together with a better identification of the modifications controlling partners of NEMO, a clearer picture of how IKK becomes activated upon cell stimulation is starting to emerge, providing new clues for how the NF-kappaB pathway could be modulated for therapeutic purposes.
NEMO是IκB激酶(IKK)复合物的调节亚基,可控制转录因子NF-κB的激活,在大多数情况下,IKK功能需要NEMO,但直到最近其确切作用方式仍不清楚。现在一系列出版物提供了有关NEMO的转录后修饰(如泛素化、SUMO化或磷酸化)如何调节其在IKK复合物中的功能的信息。这些修饰也可能调节游离NEMO的胞质池,该胞质池控制由基因毒性应激诱导的NF-κB的激活。随着对控制NEMO相互作用伙伴的修饰的更好鉴定,IKK在细胞刺激时如何被激活的更清晰图景开始浮现,为如何调节NF-κB途径用于治疗目的提供了新线索。